II. 6 Quality risk management as part of…

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.
World Health Organization
Radiopharmaceutical Production
The New GMP Annex 11 and Chapter 4 Deadline for coming into operation: 30 June 2011.
Transition from Q1- 8th to Q1- 9th edition
Annual Product Review (APR) Product Quality Review (PQR)
 Contracts  Subcontracting  Suppliers  Complaints  Corrective and preventive actions (CAPA)  Internal audits  Management reviews Management requirements.
1 Safety Instrumented Systems ANGELA E. SUMMERS, PH.D., P.E. SIS-TECH Solutions, LLC We’re Proven-in-Use.
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
Establish Verification Procedures (Task 11 / Principle 6)
What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.
S17: Field work. Session Objectives  To explain the manner in which field audit is carried out.  To explain the nature of evidence and the different.
Learning from GMP Inspections. Richard Bateman QA Specialist Pharmacist East and South East England Specialist Pharmacy Services.
Tony Gould Quality Risk Management. 2 | PQ Workshop, Abu Dhabi | October 2010 Introduction Risk management is not new – we do it informally all the time.
MANUFACTURING OF API AND INTERMEDIATES
Sampling, Identification and Testing (S.I.T.). IntroductionIntroduction Define basic principles for applying sampling, identification and testing requirements.
Water | Slide 1 of 16 January 2006 Water for Pharmaceutical Use Part 4: Commissioning, Qualification and validation Supplementary Training Modules on Good.
World Health Organization
Codex Guidelines for the Application of HACCP
Annex I: Methods & Tools prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Introduction to ISO New and modified requirements.
Annex II: Potential Applications prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Understanding ISO 22000:2005 TCISys.com.
World Health Organization
Water | Slide 1 of Water for Pharmaceutical Use Part 3: Operational considerations Supplementary Training Modules on Good Manufacturing Practice.
PRODUCT TRANSFER.
B. Neidhart, W. Wegscheider (Eds.): Quality in Chemical Measurements © Springer-Verlag Berlin Heidelberg 2000 P. RadvilaConcepts of Quality Management.
A Quality Perspective on Continuous Biomanufacturing Frank Lammers 22-Oct-2013.
Important informations
ISO / IEC : 2012 Conformity assessment – Requirements for the operation of various types of bodies performing inspection.
Annex II: Potential Applications prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
1 Chapter Nine Conducting the IT Audit Lecture Outline Audit Standards IT Audit Life Cycle Four Main Types of IT Audits Using COBIT to Perform an Audit.
Molecule-to-Market-Place Quality
Validation | Slide 1 of 27 August 2006 Validation Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series, No. 937, 2006.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
Annex II: Potential Applications prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Pharmaceutical Quality Control & current Good Manufacturing Practice
Most Common Deficiencies Cheryl O. Morton Managing Director, AIHA Laboratory Accreditation Programs, LLC.
Environmental Control and Developing a Science-based Monitoring Program Richard L. Friedman, M.S. FDA/CDER.
Visit us at E mail: Tele:
Annex II: Potential Applications prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Welcome to the FSSC Global Markets Webinar 11 September 2017, 4pm CET
Pharm (Mrs). Uche Sonny-Afoekelu,
BSB Biomanufacturing CHAPTER 4 GMP – Documentation Part I (SOP)
World Health Organization
MODULE 8: GOVERNANCE AUDIT EVIDENCE AND REVIEW
Pharmaceutical Quality Control & current Good Manufacturing Practice
Dave Ulrich, Abbvie HPCLC, Chicago Sept 20th 2016
Safety Instrumented Systems
MHRA GMP Inspection Deficiency Data Trend 2016
TOC and Pharmaceutical Industry
Water for Pharmaceutical Use
Quality Metrics for better Quality Compliance
Uncontrolled variation is the enemy of quality
Safety Instrumented Systems
Safety Accountabilities
Lesson 5: BRITE Seminar: GMP II
Quality Risk Management
Auditing Application Controls
Design Controls and Production & Process Controls
II. 4 Quality risk management as part of…
How to conduct Effective Stage-1 Audit
Radiopharmaceutical Production
Evaluate the integral {image}
Manufacture of Sterile Medicinal Products: Practical Examples
Risk based environmental monitoring solution for pharmaceutical microbiology laboratories.
Manufacture of Sterile Medicinal Products: ‘Annex 1’ - DRAFT
PROCESS VALIDATION - ACTUAL REGULATION, PERFORMING AND INSPECTION
Presentation transcript:

II. 6 Quality risk management as part of… Industry Production Competent Authorities

II.6: QRM as part of production Validation To identify the scope and extent of verification, qualification and validation activities Analytical methods Processes Equipment Cleaning methods To determine the extent for follow-up activities Sampling Monitoring Re-validation To distinguish between critical and non-critical process steps to facilitate design of a validation study ICH Q9

Integrated Quality Management EXAMPLE Integrated Quality Management Process Validation Cleaning Validation Support System Validations Computer Validation Method Validation Deviation Re-Validation Change Control CAPA Failure Investigation Out of Specification Validation Periodic Review T. Matsumura, Eisai

II.6: QRM as part of production In-process sampling & testing Evaluate the frequency and extent of in-process control testing Justify reduced testing under conditions of proven control Evaluate and justify the use of Process Analytical Technologies (PAT) in conjunction with parametric and real time release Production planning To determine appropriate production planning Dedicated Campaign or concurrent production process sequences ICH Q9